Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 60

1.

Cost Effectiveness of Routine Laryngoscopy in the Surgical Treatment of Differentiated Thyroid Cancer.

Zanocco K, Kaltman DJ, Wu JX, Fingeret A, Heller KS, Lee JA, Yeh MW, Sosa JA, Sturgeon C.

Ann Surg Oncol. 2018 Apr;25(4):949-956. doi: 10.1245/s10434-018-6356-2. Epub 2018 Feb 7.

PMID:
29417402
2.

Thyroid cancer is more likely to be detected incidentally on imaging in private hospital patients.

Zagzag J, Kenigsberg A, Patel KN, Heller KS, Ogilvie JB.

J Surg Res. 2017 Jul;215:239-244. doi: 10.1016/j.jss.2017.03.059. Epub 2017 Apr 12.

PMID:
28688654
3.

Method of Detection of Well-Differentiated Thyroid Cancers in Obese and Non-Obese Patients.

Zagzag J, Malone MK, Lopresti MA, Ogilvie JB, Patel KN, Heller KS.

PLoS One. 2016 Apr 4;11(4):e0152768. doi: 10.1371/journal.pone.0152768. eCollection 2016.

4.

Management of recurrent/persistent nodal disease in patients with differentiated thyroid cancer: a critical review of the risks and benefits of surgical intervention versus active surveillance.

Tufano RP, Clayman G, Heller KS, Inabnet WB, Kebebew E, Shaha A, Steward DL, Tuttle RM; American Thyroid Association Surgical Affairs Committee Writing Task Force.

Thyroid. 2015 Jan;25(1):15-27. doi: 10.1089/thy.2014.0098.

PMID:
25246079
5.

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS): Is there a correct answer?

Heller KS.

Thyroid. 2014 May;24(5):787-8. doi: 10.1089/thy.2014.0142. No abstract available.

PMID:
24684214
6.

Motivating adherence among adolescents with cystic fibrosis: youth and parent perspectives.

Sawicki GS, Heller KS, Demars N, Robinson WM.

Pediatr Pulmonol. 2015 Feb;50(2):127-36. doi: 10.1002/ppul.23017. Epub 2014 Mar 10.

7.

A new tool: the same dilemma.

Heller KS.

Surgery. 2013 Dec;154(6):1156-7. doi: 10.1016/j.surg.2013.05.018. No abstract available.

PMID:
24238041
8.

Clinical and therapeutic implications of Sprouty2 feedback dysregulation in BRAF V600E-mutation-positive papillary thyroid cancer.

Dultz LA, Dhar S, Ogilvie JB, Heller KS, Bar-Sagi D, Patel KN.

Surgery. 2013 Dec;154(6):1239-44; discussion 1244-5. doi: 10.1016/j.surg.2013.06.024. Epub 2013 Oct 2.

9.

Clinical utility of immunohistochemistry for the detection of the BRAF v600e mutation in papillary thyroid carcinoma.

Zagzag J, Pollack A, Dultz L, Dhar S, Ogilvie JB, Heller KS, Deng FM, Patel KN.

Surgery. 2013 Dec;154(6):1199-204; discussion 1204-5. doi: 10.1016/j.surg.2013.06.020. Epub 2013 Aug 6.

10.

Thyroid cancers detected by imaging are not necessarily small or early stage.

Malone MK, Zagzag J, Ogilvie JB, Patel KN, Heller KS.

Thyroid. 2014 Feb;24(2):314-8. doi: 10.1089/thy.2012.0651. Epub 2013 Sep 13.

PMID:
23819462
11.

The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension.

Randolph GW, Duh QY, Heller KS, LiVolsi VA, Mandel SJ, Steward DL, Tufano RP, Tuttle RM; American Thyroid Association Surgical Affairs Committee’s Taskforce on Thyroid Cancer Nodal Surgery.

Thyroid. 2012 Nov;22(11):1144-52. doi: 10.1089/thy.2012.0043. Epub 2012 Oct 19. Review.

PMID:
23083442
12.

Surgical approach and outcomes in patients with lithium-associated hyperparathyroidism.

Marti JL, Yang CS, Carling T, Roman SA, Sosa JA, Donovan P, Guoth MS, Heller KS, Udelsman R.

Ann Surg Oncol. 2012 Oct;19(11):3465-71. doi: 10.1245/s10434-012-2367-6. Epub 2012 Jun 6.

PMID:
22669448
13.

Follicular variant of papillary thyroid cancer: encapsulated, nonencapsulated, and diffuse: distinct biologic and clinical entities.

Gupta S, Ajise O, Dultz L, Wang B, Nonaka D, Ogilvie J, Heller KS, Patel KN.

Arch Otolaryngol Head Neck Surg. 2012 Mar;138(3):227-33. doi: 10.1001/archoto.2011.1466.

14.

Disparities in the initial presentation of differentiated thyroid cancer in a large public hospital and adjoining university teaching hospital.

Lim II, Hochman T, Blumberg SN, Patel KN, Heller KS, Ogilvie JB.

Thyroid. 2012 Mar;22(3):269-74. doi: 10.1089/thy.2010.0385. Epub 2012 Jan 10.

15.

Impact of the 2009 American Thyroid Association guidelines on the choice of operation for well-differentiated thyroid microcarcinomas.

Ogilvie JB, Patel KN, Heller KS.

Surgery. 2010 Dec;148(6):1222-6; discussion 1226-7. doi: 10.1016/j.surg.2010.09.007.

PMID:
21134555
16.

Is screening appropriate for occult cervical lymph node metastases in patients with well-differentiated thyroid cancer?

Heller KS.

Thyroid. 2010 Aug;20(8):933-4; author reply 934-5. doi: 10.1089/thy.2009.0451. No abstract available.

PMID:
20677999
17.

Importance of intraoperative parathyroid hormone measurement in the diagnosis of parathyroid lipoadenoma.

Lee AY, Wang BY, Heller KS.

Head Neck. 2011 Jun;33(6):917-9. doi: 10.1002/hed.21339. Epub 2010 Jan 20.

PMID:
20091680
18.

Impact of a contemplative end-of-life training program: being with dying.

Rushton CH, Sellers DE, Heller KS, Spring B, Dossey BM, Halifax J.

Palliat Support Care. 2009 Dec;7(4):405-14. doi: 10.1017/S1478951509990411.

PMID:
19939303
19.

Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.

Heller KS, Blumberg SN.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1103-7. doi: 10.1001/archoto.2009.155.

PMID:
19917922
20.

The CLABs collaborative: a regionwide effort to improve the quality of care in hospitals.

Koll BS, Straub TA, Jalon HS, Block R, Heller KS, Ruiz RE.

Jt Comm J Qual Patient Saf. 2008 Dec;34(12):713-23.

PMID:
19119725

Supplemental Content

Loading ...
Support Center